Results 221 to 230 of about 413,920 (368)

CORE-BIOPSY OF MEDIASTINAL NEOPLASMS USING A ROBOTIC DEVICE CONTROLLED BY COMPUTER TOMOGRAPHY

open access: bronze
Andrey Andreevich Pustovgar   +3 more
openalex   +1 more source

Video‐Assisted Thoracoscopic Removal of a Mediastinal Mass in a Newborn: A Case Report

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Carlo Maria Ferlini   +7 more
wiley   +1 more source

Exploring the Role of Bioprosthesis for Chest Wall Reconstruction in Pediatric Oncology

open access: yesPediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Aim of the Study Investigating the possible role of bioprosthesis in the treatment of primary chest wall Ewing sarcoma (pCWES) after major chest wall resection in the pediatric oncologic population and its role in addressing the significant controversies related to the ongoing growth process in this population. This study presents the insights
Chiara Oreglio   +11 more
wiley   +1 more source

Malignant Rhabdoid Tumors of the Liver Are Associated With Inferior Outcomes Compared to Other Extracranial Rhabdoid Tumors

open access: yesPediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Background Extracranial malignant rhabdoid tumors (eMRT) are rare, highly aggressive pediatric neoplasms. While the liver is a relatively common anatomic site of presentation, the clinical course of patients with hepatic eMRT (eMRT‐L) is not well described.
Sebastian Bühner   +16 more
wiley   +1 more source

Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA‐TMA)

open access: yesAmerican Journal of Hematology, Volume 100, Issue 11, Page 2040-2051, November 2025.
ABSTRACT Inappropriate complement activation is a key driver of hematopoietic cell transplant‐associated thrombotic microangiopathy (TA‐TMA). Treatment with narsoplimab, an inhibitor of MASP‐2, the effector enzyme of the lectin pathway, resulted in a response rate of 61% in a Phase 2 clinical trial in adults with TA‐TMA.
Michelle L. Schoettler   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy